ID: ALA3286622

Max Phase: Preclinical

Molecular Formula: C9H9Cl2NO2

Molecular Weight: 234.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCC/N=C/c1cc(Cl)cc(Cl)c1O

Standard InChI:  InChI=1S/C9H9Cl2NO2/c10-7-3-6(5-12-1-2-13)9(14)8(11)4-7/h3-5,13-14H,1-2H2/b12-5+

Standard InChI Key:  OLDVOTBHVUKWIT-LFYBBSHMSA-N

Associated Targets(non-human)

Streptococcus sp. 'group A' 3417 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.08Molecular Weight (Monoisotopic): 233.0010AlogP: 2.11#Rotatable Bonds: 3
Polar Surface Area: 52.82Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.87CX Basic pKa: 4.07CX LogP: 2.14CX LogD: 1.51
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.79Np Likeness Score: -0.88

References

1. Hu H, Mao S, Bugrysheva JV, Pruett S, Liotta DC, Scott JR, Snyder JP..  (2014)  Group A streptococcus inhibitors by high-throughput virtual screening.,  82  [PMID:24880231] [10.1016/j.ejmech.2014.05.006]

Source